Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
about
Cognitive neuropsychology of HIV-associated neurocognitive disordersMicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological diseaseSuccessful cognitive aging in persons living with HIV infectionHIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsGenetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorderSuccessful cognitive aging and health-related quality of life in younger and older adults infected with HIVHIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesClinicopathologic correlates of hepatitis C virus in brain: A pilot studyImpairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infectionThe Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewFunctional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease.The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.Persistent hijacking of brain proteasomes in HIV-associated dementia.Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults.Testing a Computerized Cognitive Training Protocol in Adults Aging With HIV-Associated Neurocognitive Disorders: Randomized Controlled Trial Rationale and Protocol.Evidence of the innate antiviral and neuroprotective properties of progranulin.HIV protease inhibitor exposure predicts cerebral small vessel disease.Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural ChinaAsymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.Significant effects of antiretroviral therapy on global gene expression in brain tissues of patients with HIV-1-associated neurocognitive disordersCCL3 genotype and current depression increase risk of HIV-associated dementiaHIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS ProjectBrain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyCCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders.Neuropsychological impairment in racial/ethnic minorities with HIV infection and low literacy levels: effects of education and reading level in participant characterizationHIVBrainSeqDB: a database of annotated HIV envelope sequences from brain and other anatomical sites.Neurocognitive functioning in acute or early HIV infection.The Wide Range Achievement Test-4 Reading subtest "holds" in HIV-infected individuals.Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors.Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy.Are time- and event-based prospective memory comparably affected in HIV infection?Neurocognitive impairment is associated with lower health literacy among persons living with HIV infection.Self-predictions of prospective memory in HIV-associated neurocognitive disorders: evidence of a metamemory deficit.Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease.No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.
P2860
Q22252615-8F585F88-55E0-48A3-B360-4DBACA345D38Q24318325-B4C212B7-8526-4BA9-870D-5461EC10B7DCQ24631698-CE0D4C03-C6D2-4DE0-AE2F-892777C60184Q24631745-E2D89C59-F418-43A3-92DB-F4998ECC4442Q26865707-0D31662F-548C-44A1-A60A-F2AA3505879AQ27000425-DA49A7B8-7E1D-4C80-B52E-2FB5FC41DEC2Q27015965-0552D07C-C32D-4654-BEFF-2CEA87290893Q27489380-B3BD25D7-167E-455A-A074-3FF17883B199Q27491050-3C2805EC-EBC8-4599-BE2A-9A8320C9B9AEQ28066725-1DE0C798-1E5D-4EAB-A473-7775DE9B36C3Q30416710-7F016DFB-DE7F-452E-8E85-EAD66222871AQ30513406-1E9D4440-37B0-4567-B1FF-8514552B9CDAQ31104394-8A1A645B-59A5-4CD8-833E-89A5D8DD8AA6Q33520783-FCDB1A62-2E2C-4CA4-AC76-D85824C0D517Q33624189-53F53D44-E5E7-4B35-9BFD-62DC9BCA73BAQ33649221-30565B59-E777-4778-AF6E-9A267D13C148Q33690042-C2816B54-4CD6-4C8A-AB6D-DA4450AADE5FQ33807507-A31AD5E8-8E50-43C9-9CB5-FF667541FDE8Q33863368-B3B4CB67-C097-47CD-8DAF-389D77B1FE80Q33927844-84228DA7-0850-4B89-9A94-84B67B2F7106Q33987146-3B9CBB5E-A634-4E62-92C4-1AC84B81E3D4Q34016222-4839DD2F-28E6-440B-BC74-94181CC9EAFDQ34072394-F9E29946-C76C-4734-82B8-3D8DE5D175A0Q34076133-2C7498CB-ECC6-4CC5-BF44-483693FFFD1FQ34125271-2C6AD94C-3428-4680-B854-A9D4CC4C8A3AQ34370880-A9D9E304-6205-49AF-9D5C-BA6C481FDCF5Q34376412-2AB39457-C0DF-4E0E-B95D-3C6FAFAA5FC6Q34446256-006C18CF-7915-4489-BD71-CF8E635897A3Q34477933-B021D6E9-5A74-40F9-BB92-098B7CF2974EQ34544921-756C6471-470F-4AD5-891B-561FD05DEC04Q34559861-EAB65B6B-3139-43F8-922E-B470901AE110Q34615228-37CEA846-3562-4858-895B-A778668692B8Q34685180-931DC6BE-7028-4C47-8B9F-5EC524371CA6Q34714286-AF3FCD93-CFC1-4960-900B-A92084081011Q34808562-68FF373C-171B-4EAC-A00A-2CEA2E1A8C04Q34847310-0D3006D2-3BD7-4183-9BDF-0F037727E03BQ34899592-D8E6DB22-DE43-4021-87D5-984CF884739FQ34974719-2040771D-2D79-45C0-ACC0-AAC79B8ACD57Q35007245-EC20C8D0-602E-4F20-BBE6-FBA3BDE88EDCQ35058529-805D1FC2-1600-48C1-855A-FD1E1E3D65D7
P2860
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
@en
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
@nl
type
label
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
@en
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
@nl
prefLabel
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
@en
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
@nl
P2093
P50
P1476
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.
@en
P2093
Alan B Frol
Benjamin B Gelman
Charles H Hinkin
Deborah Lazzaretto
Elizabeth Ryan
Elyse J Singer
Joel K Levy
Julie D Rippeth
Mariana Cherner
Thomas D Marcotte
P304
P356
10.1080/13803390490509565
P577
2004-09-01T00:00:00Z